Arthritis

Emergex Signs Contract of £1.79M with the UK Department of Health and Social Care’s UK Vaccine Network (“UKVN”) to Advance Its Novel Synthetic T Cell-Priming Set-Point Candidate Against Chikungunya Virus

Retrieved on: 
Friday, November 17, 2023

In the last decade, CHIKV has become a reemerging mosquito-transmitted virus that has spread into Europe, Asia, the Pacific Region, and the Americas, with epidemics causing severe economic impact.

Key Points: 
  • In the last decade, CHIKV has become a reemerging mosquito-transmitted virus that has spread into Europe, Asia, the Pacific Region, and the Americas, with epidemics causing severe economic impact.
  • The programme is intended to position Emergex for entry to the clinic by its completion, ready to begin a Phase-1 clinical trial.
  • Subsequently, Emergex achieved all milestones priming the CHIKV candidate for progression to the next stage of its preclinical development.
  • A Phase-2 trial for CoronaTcP and a Phase-1 trial for a Universal Influenza vaccine candidate are planned in H1 2024.

Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis

Retrieved on: 
Tuesday, November 14, 2023

is now Lead Investigator & Study Chairman for its clinical research program for Natrunix in Rheumatoid Arthritis.

Key Points: 
  • is now Lead Investigator & Study Chairman for its clinical research program for Natrunix in Rheumatoid Arthritis.
  • The company has now enrolled about 33% of the 210 patients it is recruiting for a Phase II, Double-Blind, Placebo-Controlled, Randomized study, examining Natrunix in combination with methotrexate for the treatment of Rheumatoid Arthritis.
  • I am excited to be part of a clinical trial program studying a novel approach to RA.”
    Dr. Kivitz has had a prodigious medical career treating arthritis and rheumatic diseases.
  • Dr. Kivitz has authored over 500 research articles, abstracts, and clinical studies relating to osteoarthritis, osteoporosis and rheumatoid arthritis and has lectured on his findings around the world.

Seoul Semiconductor Presents New Proposal for SunLike-Enabled Future Smart Farm

Retrieved on: 
Monday, December 18, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231218199613/en/
    A nutrient analyzer and human cell response tester in Seoul Semiconductor’s bio-laboratory (Photo: Seoul Semiconductor Co., Ltd.)
    Seoul Semiconductor used both regular white LED lights and SunLike natural spectrum LED lights to grow lettuce, a vegetable commonly used as a food ingredient.
  • Seoul Semiconductor has been operating its own plant cultivation and research farm for the past 10 years.
  • This confirms that using lighting closer to natural light in cultivation leads to higher nutrient content in plants.
  • Sunflowers, for which the natural light spectrum was not used, suffered a decrease in bee visits.

United States MAXIGESIC IV (Paracetamol + Ibuprofen) Drug Insights and Market Forecasts, 2019-2022 and 2023-2032 - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 14, 2023

The "United States MAXIGESIC IV Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States MAXIGESIC IV Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive insights about MAXIGESIC IV for acute pain in the United States.
  • A detailed picture of the MAXIGESIC IV for acute pain in the United States for the study period 2019 -2032 is provided in this report along with a detailed description of the MAXIGESIC IV for acute pain.
  • This report provides a detailed market assessment of MAXIGESIC IV for acute pain in the United States.

The Orthopaedic Research Society to Celebrate 70 Years at Their 2024 ORS Annual Meeting

Retrieved on: 
Wednesday, December 13, 2023

The Orthopaedic Research Society (ORS) seeks to support and promote musculoskeletal research that will make life easier for those affected by these debilitating disorders.

Key Points: 
  • The Orthopaedic Research Society (ORS) seeks to support and promote musculoskeletal research that will make life easier for those affected by these debilitating disorders.
  • The ORS will celebrate “70 Years of Advancing Research to Keep the World Moving” at their 2024 ORS Annual Meeting, February 2-6 in Long Beach, CA.
  • Kurt Hankenson, DVM, MS, PhD, President of the ORS Board of Directors states, "The ORS Annual Meeting is the premier conference devoted to orthopaedic research and musculoskeletal health in the world.
  • ORS member Brian Feeley, MD says, “The ORS Annual Meeting is my favorite meeting of the year.

Marijuana Drying and Curing Equipment Market Size & Trends Analysis Report 2023-2030: Focus on U.S., Canada, Germany, Australia, Uruguay, Israel, and Colombia - ResearchAndMarkets.com

Retrieved on: 
Friday, December 8, 2023

The "Marijuana Drying and Curing Equipment Market Size, Share & Trends Analysis Report By Country (U.S., Canada, Germany, Australia, Uruguay, Israel, Colombia), And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Marijuana Drying and Curing Equipment Market Size, Share & Trends Analysis Report By Country (U.S., Canada, Germany, Australia, Uruguay, Israel, Colombia), And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The number of weed cultivators has increased at a rapid rate with a rise in the number of countries legalizing marijuana.
  • This has had a positive impact on demand for marijuana drying and curing equipment, as consumer demand shifts to high quality and potent products.
  • This, in turn, is expected to drive demand for marijuana drying and curing equipment over the forecast period.

Global Single Cell Genome Sequencing Market Size, Share & Trends Analysis Report 2023-2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 6, 2023

The "Single Cell Genome Sequencing Market Size, Share & Trends Analysis By Product Type (Instruments, Reagents), By Disease Area (Cancer, Immunology), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Single Cell Genome Sequencing Market Size, Share & Trends Analysis By Product Type (Instruments, Reagents), By Disease Area (Cancer, Immunology), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global single cell genome sequencing market size is anticipated to reach USD 7.55 billion by 2030.
  • Active participation and contribution of market players toward product upgradation play an important role in the growth of the market.
  • Moreover, the emergence of next-generation sequencing (NGS) has helped the market gain tremendous traction over the past few years.

COVID-19’s impact on the vagus nerve, inflammatory reflex & long COVID: Feinstein Institutes & Karolinska Institutet study outlines potential therapies

Retrieved on: 
Wednesday, November 29, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231129335345/en/
    Dr. Kevin J. Tracey co-authored a new paper on the relationship between SARS-CoV-2 and the vagus nerve.
  • They also discussed potential therapies, particularly to reduce the progression of COVID-19 in infected patients as well as long COVID-19 treatment options.
  • “Studying the connection between COVID-19 and the vagus nerve is an important research avenue that needs further study,” said Dr. Andersson.
  • At the Feinstein Institutes, medical researchers use modern technology to develop new device-based therapies to treat disease and injury.

University of Basel Delivers First Biological Implants for Treatment of Cartilage Lesions and Osteoarthritis in Humans

Retrieved on: 
Wednesday, November 15, 2023

The Department of Biomedicine at the University of Basel and the University Hospital Basel, today announced that it delivered the first surgical procedure to treat Osteoarthritis (OA) in humans.

Key Points: 
  • The Department of Biomedicine at the University of Basel and the University Hospital Basel, today announced that it delivered the first surgical procedure to treat Osteoarthritis (OA) in humans.
  • Chondrocytes are the cell building blocks for cartilage and the University of Basel team is using them to grow new cartilage.
  • Expanding beyond focal lesions six years ago, the University of Basel team treated two patients with advanced knee OA – patients who had been scheduled for knee joint replacement.
  • The team at the University of Basel are providing folks like us with new hope.

Northwell Health Pediatric Rheumatologist Recognized for Lifetime Achievement by the American College of Rheumatology

Retrieved on: 
Tuesday, November 14, 2023

For her dedication to research and leadership in rheumatology, Northwell Health’s Cohen Children’s Medical Center (CCMC) pediatric rheumatologist and Feinstein Institutes for Medical Research scientist Barbara Anne Eberhard, MD , has been awarded top honors by the American College of Rheumatology (ACR) and the Association of Rheumatology Professionals (ARP).

Key Points: 
  • For her dedication to research and leadership in rheumatology, Northwell Health’s Cohen Children’s Medical Center (CCMC) pediatric rheumatologist and Feinstein Institutes for Medical Research scientist Barbara Anne Eberhard, MD , has been awarded top honors by the American College of Rheumatology (ACR) and the Association of Rheumatology Professionals (ARP).
  • Dr. Eberhard was recognized, and named an “ACR Master,” during the ACR Convergence 2023 annual conference which is being held November 10-15 in San Diego, California.
  • View the full release here: https://www.businesswire.com/news/home/20231114668794/en/
    Dr. Barbara Anne Eberhard was recognized for lifetime achievement by the American College of Rheumatology.
  • (Credit: Feinstein Institutes)
    The ACR Master recognition is awarded to physician-researchers who have made significant contributions to the field of rheumatology.